المؤلفون: Kendra K. Bence, William P. Esler

المصدر: Cellular and Molecular Gastroenterology and Hepatology

مصطلحات موضوعية: 0301 basic medicine, PPAR, peroxisome proliferator-activated receptor, Review, ACC, acetyl-CoA carboxylase, AST, aspartate aminotransferase, Type 2 diabetes, Bioinformatics, 0302 clinical medicine, Non-alcoholic Fatty Liver Disease, LDL, low-density lipoprotein, Nonalcoholic fatty liver disease, PDFF, proton density fat fraction, Medicine, VLDL, very low-density lipoprotein, Metabolic Syndrome, TG, triglyceride, Gastroenterology, GLP-1, glucagon-like peptide-1, FAS, fatty acid synthase, HOMA-IR, homeostatic model assessment of insulin resistance, TH, thyroid hormone, 030211 gastroenterology & hepatology, TZD, thiazolidinedione, SREBP-1c, sterol regulatory element binding protein-1c, NASH, nonalcoholic steatohepatitis, SGLT2, sodium glucose co-transporter 2, HDL, high-density lipoprotein, NAS, Nonalcoholic Fatty Liver Disease Activity Score, T2D, type 2 diabetes, DNL, de novo lipogenesis, THR, thyroid hormone receptor, digestive system, 03 medical and health sciences, Insulin resistance, ALT, alanine aminotransferase, Diabetes mellitus, FFA, free fatty acid, Animals, Humans, Obesity, Hepatology, business.industry, nutritional and metabolic diseases, ChREBP, carbohydrate response element binding protein, Lipid metabolism, T2DM, type 2 diabetes mellitus, medicine.disease, ASO, anti-sense oligonucleotide, DGAT, diacylglycerol O-acyltransferase, digestive system diseases, FGF, fibroblast growth factor, Treg, regulatory T cells, CI, confidence interval, OR, odds ratio, 030104 developmental biology, Diabetes Mellitus, Type 2, FXR, Farnesoid X receptor, NAFLD, nonalcoholic fatty liver disease, Metabolic syndrome, Steatosis, business, Dyslipidemia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14a0440d3ac498ff260c68d959a6ab3Test
https://doi.org/10.1016/j.jcmgh.2019.04.007Test

المؤلفون: Gaia Cattadori, Giuseppe Ambrosio, Paola Pantanetti

المصدر: Diabetes Research and Clinical Practice. 157:107835

مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, glucagon-like peptide 1 receptor agonists, Endocrinology, Diabetes and Metabolism, DPP4 inhibitors, Type 2 diabetes mellitus, heart failure, sodium-glucose co-transporter 2 inhibitors, 030209 endocrinology & metabolism, Type 2 diabetes, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Diabetes mellitus, Internal Medicine, Humans, Hypoglycemic Agents, Medicine, 030212 general & internal medicine, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, Glycemic, Glucose lowering, business.industry, Type 2 Diabetes Mellitus, General Medicine, Guideline, medicine.disease, Metformin, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart failure, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8198d03e2e66a1b142e301f1eb751231Test
https://doi.org/10.1016/j.diabres.2019.107835Test